- Filed
- Dec 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Nov 26, 2025 | 207.03M sh |
| Stock Issued | FY 2023 · Jan 31, 2023 | 510K sh |
| Capex | FY 2023 · Jan 31, 2023 | $0 |
| Capex | FY 2023 · Jan 31, 2022 | $73K |
| Shares Diluted | FY 2023 · Jan 31, 2022 | 205.98M sh |
| Operating Cash Flow restated | FY 2023 · Jan 31, 2022 | −$269.63K |
| Current Liabilities restated | FY 2023 · Jan 31, 2022 | $1.74M |
| Total Liabilities | FY 2023 · Jan 31, 2022 | $2.03M |
| Current Assets | FY 2023 · Jan 31, 2022 | $3.06M |
| Total Assets | FY 2023 · Jan 31, 2022 | $3.6M |
| Eps Diluted | FY 2023 · Jan 31, 2022 | $0.00 |
| Sga Expense restated | FY 2023 · Jan 31, 2022 | $941.34K |
| Net Income restated | FY 2023 · Jan 31, 2022 | $909.56K |
| Operating Income restated | FY 2023 · Jan 31, 2022 | $1.13M |
| Gross Profit | FY 2023 · Jan 31, 2022 | $2.07M |
| Cost Of Revenue | FY 2023 · Jan 31, 2022 | $3.55M |
| Revenue | FY 2023 · Jan 31, 2022 | $5.61M |
| Stockholders Equity | FY 2023 · Jan 31, 2021 | $96.36K |